Sermonix Pharmaceuticals

Privately held biopharmaceutical company developing lasofoxifene, an investigational endocrine therapy for HR+/HER2- metastatic breast cancer treatment.

Sermonix Pharmaceuticals is a biotech company in Columbus, United States, founded in 2014. It has raised $66.0M across 2 rounds, most recently a $40.0M Venture Round in November 2021.

Headquarters
Columbus
Employees
11–50
Founded
2014
Total Funding
$66.0M
Last Round
$40.0M Venture RoundNov 2021
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 1 investor for this company. to use credits for reveals, or explore the API.

About

Sermonix Pharmaceuticals is a privately held biopharmaceutical company developing innovative therapeutics to specifically treat metastatic breast cancers (mBC). The company's lead candidate, lasofoxifene, is being evaluated as a neoadjuvant endocrine therapy in molecularly selected HR+/HER2-, locally advanced breast cancer in a Phase 2 trial with Quantum Leap Healthcare Collaborative, and has shown promising early activity in suppressing the Ki67 protein in both premenopausal and postmenopausal patients.

Funding History

Data from Indexed.vcUpdated
Venture RoundVenture RoundNov 2021
$40.0M

1 more funding event

  • Series A20191 investor

Funding: Series A through Venture Round. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Marketing & SEO ×3
  • Backend ×1
  • Cloud/Infrastructure ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech
Private EquityTotal funding$2.3BFeb 2020
Treeline Biosciences

Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...

Watertown, United States51–200Biotech
Extension RoundTotal funding$821.8MSep 2025
LifeMine

Therapeutics company working in drug discovery and development using fungi with genomics approach...

Watertown, United States51–200Biotech
Venture RoundTotal funding$816.0MAug 2026
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech
Private EquityTotal funding$647.0MFeb 2026
Chai Discovery

Chai Discovery builds frontier AI to predict and reprogram interactions between biochemical molec...

San Francisco, United States11–50Biotech
Series CTotal funding$630.0MJul 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Sermonix Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/sermonix-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/sermonix-pharmaceuticals" alt="Sermonix Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>